Decreased focal adhesion kinase suppresses papilloma formation during experimental mouse skin carcinogenesis

G W McLean1, K Brown, M I Arbuckle

  • 1Beatson Institute for Cancer Research, Garscube Estate, Bearsden, Glasgow G61 1BD, United Kingdom.

Cancer Research
|December 4, 2001
PubMed

Insights

Reduced focal adhesion kinase (FAK) expression in mice lowered tumor formation but did not affect malignant conversion. This suggests FAK is crucial for early tumor development, particularly in ras-driven cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Focal adhesion kinase (FAK) is often elevated in epithelial cancers.
  • The in vivo role of FAK in tumor development remains largely unexplored.

Purpose of the Study:

  • To investigate the in vivo role of focal adhesion kinase (FAK) in tumor development.
  • To determine if FAK expression levels influence the formation and malignant conversion of chemically induced skin tumors.

Main Methods:

  • Utilized fak +/- heterozygous mice and wild-type fak +/+ littermates.
  • Administered 7,12-dimethylbenz[a]anthracene to induce papilloma formation.
  • Assessed FAK protein expression in skin and papillomas.
  • Evaluated keratinocyte cellular responses downstream of ras activation in vitro.

Main Results:

  • Fak +/- mice exhibited reduced 7,12-dimethylbenz[a]anthracene-induced papilloma formation, correlating with lower FAK protein levels in the skin.
  • The rate of malignant conversion from papillomas to carcinomas was similar between fak +/- and fak +/+ mice.
  • Elevated FAK protein levels in papillomas of fak +/- mice reached wild-type levels, potentially explaining the lack of difference in malignant conversion.
  • Keratinocyte FAK protein expression was essential for downstream cellular responses to ras activation, such as extracellular signal-regulated kinase activation.

Conclusions:

  • FAK protein expression is critical for the initiation of tumor development in vivo, especially in the context of ras mutations.
  • While FAK limits initial tumor formation, its role in the malignant progression of established tumors may be compensated by other pathways.